Page 20 - GPD-2-2

Gene & Protein in Disease MOR in cancer

23. Hughes J, Smith TW, Kosterlitz HW, et al., 1975, Identification 56 Suppl 1: 205–212.
of two related pentapeptides from the brain with potent https://doi.org/10.1016/j.neuropharm.2008.07.033
opiate agonist activity. Nature, 258(5536): 577–580.
37. Mansour A, Fox CA, Akil H, et al., 1995, Opioid-receptor
https://doi.org/10.1038/258577a0
mRNA expression in the rat CNS: Anatomical and
24. Rosenblum A, Marsch LA, Joseph H, et al., 2008, Opioids functional implications. Trends Neurosci, 18(1): 22–29.
and the treatment of chronic pain: Controversies, current https://doi.org/10.1016/0166-2236(95)93946-u
status, and future directions. Exp Clin Psychopharmacol,
16: 405–416. 38. Xia Y, Haddad GG, 1991, Ontogeny and distribution of
opioid receptors in the rat brainstem. Brain Res, 549(2):
https://doi.org/10.1037/a0013628
181–193.
25. Dickenson AH, 1994, The localization and mechanisms of https://doi.org/10.1016/0006-8993(91)90457-7
action of opioids. Eksp Klin Farmakol, 57(6): 3–12.
39. Wittert G, Hope P, Pyle D, 1996, Tissue distribution of
26. Bovill JG, 1997, Mechanisms of actions of opioids and non- opioid receptor gene expression in the rat. Biochem Biophys
steroidal anti-inflammatory drugs. Eur J Anaesthesiol Suppl, Res Commun, 218(3): 877–881.
15: 9–15.
https://doi.org/10.1006/bbrc.1996.0156
https://doi.org/10.1097/00003643-199705001-00003
40. Peng J, Sarkar S, Chang SL, 2012, Opioid receptor expression
27. Nelson AD, Camilleri M, 2016, Opioid-induced constipation: in human brain and peripheral tissues using absolute
Advances and clinical guidance. Ther Adv Chronic Dis, 7(2): quantitative real-time RT-PCR. Drug Alcohol Depend,
121–134.
124(3): 223–228.
https://doi.org/10.1177/2040622315627801
https://doi.org/10.1016/j.drugalcdep.2012.01.013
28. Pattinson KT, 2008, Opioids and the control of respiration. 41. Mollereau C, Parmentier M, Mailleux P, et al., 1994, ORL1,
Br J Anaesth, 100(6): 747–758. a novel member of the opioid receptor family. Cloning,
https://doi.org/10.1093/bja/aen094 functional expression and localization. FEBS Lett, 341(1):
33–38.
29. Mao J, 2002, Opioid-induced abnormal pain sensitivity:
Implications in clinical opioid therapy. Pain, 100: 213–217. https://doi.org/10.1016/0014-5793(94)80235-1
https://doi.org/10.1016/S0304-3959(02)00422-0 42. Meunier JC, Mollereau C, Toll L, et al., 1995, Isolation and
structure of the endogenous agonist of opioid receptor-like
30. DeLeo JA, Tanga FY, Tawfik VL, 2004, Neuroimmune ORL1 receptor. Nature, 377(6549): 532–535.
activation and neuroinflammation in chronic pain and
opioid tolerance/hyperalgesia. Neuroscientist, 10(1): 40–52. https://doi.org/10.1038/377532a0
https://doi.org/10.1177/1073858403259950 43. Akil H, Watson SJ, Young E, et al., 1984, Endogenous opioids:
Biology and function. Annu Rev Neurosci, 7: 223–255.
31. Stein C, Zollner C, 2009, Opioids and sensory nerves. Handb
Exp Pharmacol, 194: 495–518. https://doi.org/10.1146/annurev.ne.07.030184.001255
https://doi.org/10.1007/978-3-540-79090-7_14 44. Kieffer BL, 1995, Recent advances in molecular recognition
and signal transduction of active peptides: Receptors for
32. Kosten TR, 1990, Neurobiology of abused drugs. Opioids opioid peptides. Cell Mol Neurobiol, 15(6): 615–635.
and stimulants. J Nerv Ment Dis, 178(4): 217–227.
https://doi.org/10.1007/BF02071128
https://doi.org/10.1097/00005053-199004000-00001
45. Colvin LA, Bull FB, Hales TG, 2019, Perioperative opioid
33. Colasanti A, Rabiner EA, Lingford-Hughes A, et al., 2011, analgesia-when is enough too much? A review of opioid-
Opioids and anxiety. J Psychopharmacol, 25: 1415–1433.
induced tolerance and hyperalgesia. Lancet, 393(10180):
34. Waldhoer M, Bartlett SE, Whistler JL, 2004, Opioid 1558–1568.
receptors. Annu Rev Biochem, 73: 953–990.
https://doi.org/10.1016/S0140-6736(19)30430-1
https://doi.org/10.1146/annurev.biochem.73.011303.073940
46. Streicher JM, Bilsky EJ, 2018, Peripherally acting mu-opioid
35. Zaki PA, Bilsky EJ, Vanderah TW, et al., 1996, Opioid receptor antagonists for the treatment of opioid-related
receptor types and subtypes: The delta receptor as a model. side effects: Mechanism of action and clinical implications.
Annu Rev Pharmacol Toxicol, 36: 379–401. J Pharm Pract, 31(6): 658–669.
https://doi.org/10.1146/annurev.pa.36.040196.002115 https://doi.org/10.1177/0897190017732263
36. Kieffer BL, Evans CJ, 2009, Opioid receptors: From binding 47. Trang T, Al-Hasani R, Salvemini D, et al., 2015, Pain and
sites to visible molecules in vivo. Neuropharmacology, poppies: The good, the bad, and the ugly of opioid analgesics.

Volume 2 Issue 2 (2023) 14 https://doi.org/10.36922/gpd.282